Cargando…

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia

PURPOSE: Pseudomonas aeruginosa is recognized as a major cause of severe and potentially life-threatening infection. However, P. aeruginosa isolates with the phenotype of being carbapenem resistant and cephalosporin susceptible (Carb-R/Ceph-S) have not been thoroughly characterized to date. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuang, Jia, Xiaojiong, Li, Congya, Zou, Hua, Liu, Hang, Guo, Yuanbiao, Zhang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108401/
https://www.ncbi.nlm.nih.gov/pubmed/30154669
http://dx.doi.org/10.2147/IDR.S174876
_version_ 1783350140372779008
author Li, Shuang
Jia, Xiaojiong
Li, Congya
Zou, Hua
Liu, Hang
Guo, Yuanbiao
Zhang, Liping
author_facet Li, Shuang
Jia, Xiaojiong
Li, Congya
Zou, Hua
Liu, Hang
Guo, Yuanbiao
Zhang, Liping
author_sort Li, Shuang
collection PubMed
description PURPOSE: Pseudomonas aeruginosa is recognized as a major cause of severe and potentially life-threatening infection. However, P. aeruginosa isolates with the phenotype of being carbapenem resistant and cephalosporin susceptible (Carb-R/Ceph-S) have not been thoroughly characterized to date. The aim of this study was to assess the mechanisms, risk factors, and clinical impact of Carb-R/Ceph-S P. aeruginosa bacteremia on mortality. PATIENTS AND METHODS: We conducted a retrospective case–case–control study of the risk factors and clinical outcomes of hospitalized patients with Carb-R/Ceph-S P. aeruginosa bacteremia from 2011 to 2017 in Chongqing, China. Case patients infected with Carb-R/Ceph-S P. aeruginosa, carbapenem-susceptible and cephalosporin-susceptible (Carb-S/Ceph-S) P. aeruginosa, and controls with no P. aeruginosa bacteremia were compared at a ratio of 1:1:2. Real-time reverse transcription polymerase chain reaction was performed to assess resistance mechanisms. A multivariate logistic regression model was performed to investigate several potential predictors for mortality. RESULTS: We collected 63 Carb-R/Ceph-S P. aeruginosa isolates during the study period. None of these isolates possessed carbapenemase or extended-spectrum β-lactamase-encoding genes. The overall 30-day mortality rate was 27.0%. Real-time reverse transcription polymerase chain reaction analysis showed that an overexpression of efflux systems and decreased expression of OprD were associated with Carb-R/Ceph-S P. aeruginosa. Multivariate analysis indicated that 30-day readmission, central venous catheters, and exposure to carbapenems were unique independent predictors for acquiring Carb-R/Ceph-S P. aeruginosa bacteremia. Additionally, hematologic malignancy was a peculiar predictor for Carb-S/Ceph-S P. aeruginosa bacteremia. Notably, total parenteral nutrition was the only common factor of both Carb-R/Ceph-S and Carb-S/Ceph-S groups compared to controls. In a multivariate analysis for the outcome, intensive care unit admission and septic shock were identified as the independent predictors for mortality. CONCLUSION: Our findings can potentially improve the ability of physicians to identify the high-risk patients, and carbapenems were noted to potentially increase the risk of Carb-R/Ceph-S P. aeruginosa. Additionally, cephalosporin should be considered a valuable therapeutic option for such cases of bacteremia.
format Online
Article
Text
id pubmed-6108401
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61084012018-08-28 Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia Li, Shuang Jia, Xiaojiong Li, Congya Zou, Hua Liu, Hang Guo, Yuanbiao Zhang, Liping Infect Drug Resist Original Research PURPOSE: Pseudomonas aeruginosa is recognized as a major cause of severe and potentially life-threatening infection. However, P. aeruginosa isolates with the phenotype of being carbapenem resistant and cephalosporin susceptible (Carb-R/Ceph-S) have not been thoroughly characterized to date. The aim of this study was to assess the mechanisms, risk factors, and clinical impact of Carb-R/Ceph-S P. aeruginosa bacteremia on mortality. PATIENTS AND METHODS: We conducted a retrospective case–case–control study of the risk factors and clinical outcomes of hospitalized patients with Carb-R/Ceph-S P. aeruginosa bacteremia from 2011 to 2017 in Chongqing, China. Case patients infected with Carb-R/Ceph-S P. aeruginosa, carbapenem-susceptible and cephalosporin-susceptible (Carb-S/Ceph-S) P. aeruginosa, and controls with no P. aeruginosa bacteremia were compared at a ratio of 1:1:2. Real-time reverse transcription polymerase chain reaction was performed to assess resistance mechanisms. A multivariate logistic regression model was performed to investigate several potential predictors for mortality. RESULTS: We collected 63 Carb-R/Ceph-S P. aeruginosa isolates during the study period. None of these isolates possessed carbapenemase or extended-spectrum β-lactamase-encoding genes. The overall 30-day mortality rate was 27.0%. Real-time reverse transcription polymerase chain reaction analysis showed that an overexpression of efflux systems and decreased expression of OprD were associated with Carb-R/Ceph-S P. aeruginosa. Multivariate analysis indicated that 30-day readmission, central venous catheters, and exposure to carbapenems were unique independent predictors for acquiring Carb-R/Ceph-S P. aeruginosa bacteremia. Additionally, hematologic malignancy was a peculiar predictor for Carb-S/Ceph-S P. aeruginosa bacteremia. Notably, total parenteral nutrition was the only common factor of both Carb-R/Ceph-S and Carb-S/Ceph-S groups compared to controls. In a multivariate analysis for the outcome, intensive care unit admission and septic shock were identified as the independent predictors for mortality. CONCLUSION: Our findings can potentially improve the ability of physicians to identify the high-risk patients, and carbapenems were noted to potentially increase the risk of Carb-R/Ceph-S P. aeruginosa. Additionally, cephalosporin should be considered a valuable therapeutic option for such cases of bacteremia. Dove Medical Press 2018-08-20 /pmc/articles/PMC6108401/ /pubmed/30154669 http://dx.doi.org/10.2147/IDR.S174876 Text en © 2018 Li et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Li, Shuang
Jia, Xiaojiong
Li, Congya
Zou, Hua
Liu, Hang
Guo, Yuanbiao
Zhang, Liping
Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title_full Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title_fullStr Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title_full_unstemmed Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title_short Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
title_sort carbapenem-resistant and cephalosporin-susceptible pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108401/
https://www.ncbi.nlm.nih.gov/pubmed/30154669
http://dx.doi.org/10.2147/IDR.S174876
work_keys_str_mv AT lishuang carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT jiaxiaojiong carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT licongya carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT zouhua carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT liuhang carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT guoyuanbiao carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia
AT zhangliping carbapenemresistantandcephalosporinsusceptiblepseudomonasaeruginosaanotablephenotypeinpatientswithbacteremia